ORPEA

6 acquisitions in Europe: 4,713 beds in 3 countries - Seite 3

• quality assets, with most of them being recent, in strategic locations in major European cities;
• an excellent reputation with regard to the quality of care provided to residents and patients at local or national level;
• medium-sized groups, which are easier to integrate and meet ORPEA's strict financial criteria.

In just six months, thanks to the experience of the local management teams and their long-standing involvement in the sector, the group has thus been able to seize the best opportunities, representing 42 facilities, or 4,713 beds, of which 20% are under development. These acquisitions represent additional full-year revenue of over €210 million at maturity, i.e. within the next 2 to 3 years, with significant leverage on profitability.

ORPEA is thus consolidating its position as world leader in long-term care, with 1,156 facilities, representing 116,514 beds, of which 90,155 are open, and a record growth pipeline of 26,359 beds under construction.

2021 revenue growth target raised to > +7.5%

The strong upward trend in occupancy rates across all geographical zones, which began in March and gathered pace in June, combined with the contribution of the new selective acquisitions, has led the Group to raise its annual revenue growth target for 2021 to more than 7.5%, or at least €4,215m (compared to the previous target of at least 6%, or €4,155m).

Yves Le Masne, Chief Executive Officer of ORPEA, concludes:

"The acquisitions of FirstCare, Belmont House, Sensato AG, Hestia and part of the Sanitas facilities have enabled ORPEA to achieve leading positions or to strengthen its care offering in markets with growing needs, requiring the development of an offering that meets the highest standards of quality care. With these selective acquisitions, ORPEA is once again demonstrating the strength of its decentralised model and its ability to identify value-creating opportunities thanks to the experience of its teams in each of its geographical zones.

Bolstered by this momentum and a rapid recovery in occupancy rates, the Group can now raise its 2021 revenue target to more than €4,215 million and, above all, further secure sustained growth for the coming years.

At the same time, ORPEA is continuing its long-term growth momentum on a global level through selective expansion and the creation of new facilities in countries with strong purchasing power, and which require the deployment of a quality offer."